sp-624
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2020 (NCT04479852)
Timeline
Indications
Mechanism of action
SIRT6 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06570369 | Phase 1 | Aug 22, 2024 | Sirtsei Pharmaceuticals, Inc. |
| NCT06254612 | Phase 2 | Mar 25, 2024 | Rho, Inc., Sirtsei Pharmaceuticals, Inc. |
| NCT04510298 | Phase 1/Phase 2 (Phase 2) | Oct 15, 2020 | Sirtsei Pharmaceuticals, Inc. |
| NCT04479852 | Phase 2 | Sep 30, 2020 | Sirtsei Pharmaceuticals, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sirtsei Pharmaceuticals, Inc. | For profit | 4 | 4 | 2 | 2020 |
| Rho, Inc. | For profit | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1